GOLDMAN SACHS GROUP INC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 190 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$2,239,192
-54.6%
658,586
-1.8%
0.00%
-100.0%
Q2 2023$4,927,807
-47.2%
670,450
-25.6%
0.00%
-50.0%
Q1 2023$9,329,647
+1.3%
900,545
+15.5%
0.00%0.0%
Q4 2022$9,207,608
-4.4%
779,645
+70.0%
0.00%0.0%
Q3 2022$9,628,000
-32.3%
458,722
+0.1%
0.00%
-33.3%
Q2 2022$14,227,000
-0.8%
458,335
+31.2%
0.00%0.0%
Q1 2022$14,343,000
+4.5%
349,317
+10.7%
0.00%0.0%
Q4 2021$13,723,000
-61.3%
315,685
-55.4%
0.00%
-62.5%
Q3 2021$35,431,000
-14.1%
707,621
+8.0%
0.01%
-11.1%
Q2 2021$41,265,000
-7.2%
655,100
+36.9%
0.01%
-18.2%
Q1 2021$44,446,000
-44.9%
478,371
-46.9%
0.01%
-47.6%
Q4 2020$80,694,000
+21.4%
900,615
+40.0%
0.02%
+10.5%
Q3 2020$66,471,000
+10.1%
643,281
-15.7%
0.02%
+5.6%
Q2 2020$60,357,000
+8.0%
763,224
-21.0%
0.02%
-10.0%
Q1 2020$55,889,000
-7.9%
965,940
-14.1%
0.02%
+33.3%
Q4 2019$60,693,000
+20.4%
1,124,983
+16.7%
0.02%0.0%
Q3 2019$50,389,000
+18.4%
963,835
+9.4%
0.02%
+25.0%
Q2 2019$42,543,000
+55.0%
880,624
+62.1%
0.01%
+50.0%
Q1 2019$27,442,000
-41.9%
543,202
-31.8%
0.01%
-46.7%
Q4 2018$47,209,000
-30.3%
796,373
-22.7%
0.02%
-16.7%
Q3 2018$67,776,000
+26.0%
1,029,575
-3.3%
0.02%
+20.0%
Q2 2018$53,779,000
+11.6%
1,065,143
+16.4%
0.02%
+25.0%
Q1 2018$48,175,000
+32.0%
915,003
+16.5%
0.01%
+33.3%
Q4 2017$36,494,000
+333.2%
785,312
+277.1%
0.01%
+350.0%
Q3 2017$8,424,000
+44.9%
208,276
+21.5%
0.00%0.0%
Q2 2017$5,813,000
+52.9%
171,428
+30.9%
0.00%
+100.0%
Q1 2017$3,803,000
-79.1%
130,975
-76.4%
0.00%
-80.0%
Q4 2016$18,213,000
-30.9%
554,597
-33.6%
0.01%
-37.5%
Q3 2016$26,342,000
+12.0%
835,448
-0.1%
0.01%
+14.3%
Q2 2016$23,511,000
+101.7%
836,112
+160.7%
0.01%
+40.0%
Q1 2016$11,658,000
-1.2%
320,741
+8.7%
0.01%
+25.0%
Q4 2015$11,801,000
+66.5%
294,949
+18.5%
0.00%
+100.0%
Q3 2015$7,089,000
-41.6%
248,823
-32.5%
0.00%
-50.0%
Q2 2015$12,145,000
+73.0%
368,578
+51.0%
0.00%
+100.0%
Q1 2015$7,020,000
-0.8%
244,106
-6.1%
0.00%0.0%
Q4 2014$7,079,000
-5.1%
259,953
-25.8%
0.00%0.0%
Q3 2014$7,463,000
+14.9%
350,206
+21.0%
0.00%0.0%
Q2 2014$6,498,000
-7.2%
289,307
+4.5%
0.00%0.0%
Q1 2014$6,999,000
+1.9%
276,964
-7.3%
0.00%0.0%
Q4 2013$6,866,000
+23.6%
298,674
+2.4%
0.00%0.0%
Q3 2013$5,557,000
+123.7%
291,689
+69.4%
0.00%
+100.0%
Q2 2013$2,484,000
-32.8%
172,194
-25.3%
0.00%
-50.0%
Q4 2012$3,698,000
+15.3%
230,553
+2.2%
0.00%
+100.0%
Q3 2012$3,206,000
+29.2%
225,616
+37.7%
0.00%0.0%
Q2 2012$2,482,000
+5.4%
163,826
+11.3%
0.00%0.0%
Q1 2012$2,355,000147,1730.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders